This makes it accessible to a broader range of individuals, catering to those with dietary restrictions or specific health considerations
FDA approved in November 2023 The FDA recently approved a new Eli Lilly drug, Zepbound (tirzepatide), for chronic weight management in adults with at least one weight-related health condition
Effect of Daily Liraglutide on Body Weight: While liraglutide also led to reductions in body weight, the effect was not as pronounced as that seen with semaglutide
Interestingly, some macrolides themselves can affect stomach emptying, which means combining them with semaglutide could amplify digestive slowdown
Were here to help you lose weight, regain energy, and feel like yourself again
The most-recent Drug Safety-related Labeling Changes (SrLC) for Zepbound include guidance on not sharing Zepbound KwikPens between patients